Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T17:37:34.689Z.
Consensus retrieved: 2026-10-06T14:46:25.846Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T17:37:34.689Z.
Quote observation: 2026-10-06T17:35:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e005637c0728ee7719d987fd9d1ed1bb4b4a72c9577e4c0c1fad472fb0ddb1d0
Forward PE Ratio (N/A) = Dated Quote Price ($4.11) / Consensus Forward EPS ($-3.08)
FORWARD PE RATIO
N/A
Outset Medical, Inc.
Market Cap
$76.22M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Outset Medical, Inc. (OM) | $76.22M | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $76.14M | N/A |
| Hyperfine, Inc. (HYPR)vs › | $76.64M | N/A |
| Pulmonx Corporation (LUNG)vs › | $77.08M | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.05M | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.96M | 8.60 |
| Nutriband Inc. (NTRB)vs › | $80.11M | 4.20 |
| MindWalk Holdings Corp. (HYFT)vs › | $71.61M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $4.11, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-3.08 | $-3.10 – $-3.07 | 1 | n/m |
| 2027-12-31 | $-2.29 | $-2.35 – $-2.23 | 2 | n/m |
| 2028-12-31 | $-1.85 | $-1.86 – $-1.84 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
